HEY, $AMRS news
Amyris Signs Multi-Year Collaboration Extension with Kuraray
5 minutes ago - DJNF
Amyris Signs Multi-Year Collaboration Extension with Kuraray
Includes Joint Marketing of Products
EMERYVILLE, Calif., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed with its long-time partner Kuraray Co., LTD (TYO:3405) a multi-year extension to their collaboration agreement for the use of Amyris's Biofene(R) branded ß-Farnesene in liquid farnesene rubber ("LFR"
and farnesene-based elastomer applications. This collaboration, which originally began in 2011, features increased farnesene supply to Kuraray and joint marketing of products to industry and end-customers.
Amyris's sugar cane-derived Biofene forms the basis for a wide range of products varying from specialty products such as cosmetics, perfumes, detergents and industrial lubricants, to transportation fuels such as diesel and jet fuel. As a tailor made pure hydrocarbon it provides numerous advantages when compared to petroleum-based oils and chemicals and is renewable, contributing to a sustainable future.
Farnesene Fueling Better Products Across the World -- Including Tires
Kuraray's recent technological successes with rubber containing farnesene includes an enhanced synthetic additive for tire manufacturers. Its novel LFR and other farnesene- containing rubber materials add substantial grip and cornering capability to tires, particularly in cold, snow and ice conditions. In addition, its hydrogenated styrenic-farnesene copolymer ("HSFC" has demonstrated superior shock absorption in products ranging from footwear to specialty construction materials.
"We are delighted to extend our relationship with Kuraray," said John Melo, CEO of Amyris. "Introducing a novel molecule to industry requires patience and creativity. However, Kuraray's technical expertise and customer relationships have reached the point where their products are now becoming mainstream and this, in turn, is fueling further broadening market adoption of our farnesene for a variety of products."
"Kuraray has many years' experience working with farnesene, which we believe has many end-market applications," said Mr. Kenichi Abe, President of Kuraray's Isoprene business. "Our collaboration with Amyris and their breakthrough-ability to produce farnesene at industrial scale, and at competitive price, enables Kuraray to provide its customers products with superior performance and that are renewably sourced."
About Amyris
Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise(R) products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.
Forward-Looking Statements
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as market adoption of farnesene) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity at Amyris's Brotas facility, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on November 9, 2016. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Amyris, the Amyris logo and Biofene are registered trademarks of Amyris, Inc. All other trademarks are trademarks of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
investor@amyris.com
pr@amyris.com
(MORE TO FOLLOW) Dow Jones Newswires
December 01, 2016 08:30 ET (13:30 GMT)
« Back to Stocks News
Amyris Signs Multi-Year Collaboration Extension with Kuraray
5 minutes ago - DJNF
Amyris Signs Multi-Year Collaboration Extension with Kuraray
Includes Joint Marketing of Products
EMERYVILLE, Calif., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed with its long-time partner Kuraray Co., LTD (TYO:3405) a multi-year extension to their collaboration agreement for the use of Amyris's Biofene(R) branded ß-Farnesene in liquid farnesene rubber ("LFR"
and farnesene-based elastomer applications. This collaboration, which originally began in 2011, features increased farnesene supply to Kuraray and joint marketing of products to industry and end-customers. Amyris's sugar cane-derived Biofene forms the basis for a wide range of products varying from specialty products such as cosmetics, perfumes, detergents and industrial lubricants, to transportation fuels such as diesel and jet fuel. As a tailor made pure hydrocarbon it provides numerous advantages when compared to petroleum-based oils and chemicals and is renewable, contributing to a sustainable future.
Farnesene Fueling Better Products Across the World -- Including Tires
Kuraray's recent technological successes with rubber containing farnesene includes an enhanced synthetic additive for tire manufacturers. Its novel LFR and other farnesene- containing rubber materials add substantial grip and cornering capability to tires, particularly in cold, snow and ice conditions. In addition, its hydrogenated styrenic-farnesene copolymer ("HSFC"
has demonstrated superior shock absorption in products ranging from footwear to specialty construction materials. "We are delighted to extend our relationship with Kuraray," said John Melo, CEO of Amyris. "Introducing a novel molecule to industry requires patience and creativity. However, Kuraray's technical expertise and customer relationships have reached the point where their products are now becoming mainstream and this, in turn, is fueling further broadening market adoption of our farnesene for a variety of products."
"Kuraray has many years' experience working with farnesene, which we believe has many end-market applications," said Mr. Kenichi Abe, President of Kuraray's Isoprene business. "Our collaboration with Amyris and their breakthrough-ability to produce farnesene at industrial scale, and at competitive price, enables Kuraray to provide its customers products with superior performance and that are renewably sourced."
About Amyris
Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise(R) products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.
Forward-Looking Statements
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as market adoption of farnesene) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity at Amyris's Brotas facility, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on November 9, 2016. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Amyris, the Amyris logo and Biofene are registered trademarks of Amyris, Inc. All other trademarks are trademarks of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
investor@amyris.com
pr@amyris.com
(MORE TO FOLLOW) Dow Jones Newswires
December 01, 2016 08:30 ET (13:30 GMT)
« Back to Stocks News
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
